series-b
Stage
2
Investors
About
Zafrens develops a benchtop high-throughput screening platform that integrates longitudinal cellular imaging with built-in mRNA sequencing at single-cell resolution, enabling large-scale mapping of causal biological relationships for drug discovery and cell/gene therapy applications.
Explore Zafrens's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.